The Week

Prologis fell 3.11% this week to close at $128.91, while the S&P 500 lost 0.27%, leaving the stock roughly 2.84 percentage points behind the benchmark. It was not a straight-line decline: Monday (28 Sep) opened at $133.09 and touched a weekly high of $134.34, before drifting lower each day. Thursday (1 Oct) marked the week’s low at $127.29, and Friday recovered modestly to $128.91. Weekly amplitude was 5.3%, and average daily turnover of 4.5m shares ran about 39% above the median, a clear pickup in activity.

Key Events

The week was dominated by regulatory disclosures around Prologis’ deal for SEGRO. On Monday (28 Sep), SEGRO shareholders voted in favour of the scheme at a court meeting, and a wave of Form 8.3 filings followed from firms including Capital Group, FIL Limited, State Street Global Advisors and Cohen & Steers, which disclosed a 3.0145% stake in Prologis under Takeover Code rules. Through the rest of the week, Amundi, UBS Asset Management, L&G, APG and Syquant Capital submitted similar disclosures. Brief market notes on Wednesday and Thursday said the stock underperformed rivals. On Saturday (3 Oct), Prologis declared a R$0.3140736500 per unit dividend for Q3 2026, payable 6 Oct.

Analyst Ratings

Of the 18 firms covering the stock, 7 rate it buy, 3 overweight, 7 hold and 1 no opinion; none rate it underweight or sell. The consensus rating is buy, with a consensus target of $158.23, about 22.7% above the latest price. The target range runs from $140 to $170, so dispersion is not trivial. Within the REITs industry, the stock ranks 39th out of 150 names by analyst rating.

The Week Ahead

Macro data is fairly dense next week: the S&P Global services PMI final and ISM non-manufacturing PMI land on Monday (5 Oct), international trade data follows on Tuesday (6 Oct), and EIA crude inventories on Wednesday (7 Oct). The bigger item sits further out: Prologis reports Q3 FY2026 earnings before the open on Thursday, 15 Oct, with consensus estimates at EPS of $0.7766 and revenue of $2.216bn.

In Short

This week’s price action and the SEGRO deal progress moved in parallel: the stock fell and lagged the market, while institutional disclosures tied to the transaction kept coming. The tension to watch is simple: the price has drifted back near the 60-day range low at $127.29, yet the consensus target still implies roughly 23% upside from spot. The 15 Oct quarterly report is the next checkpoint for whether the valuation implied by that target is still justified.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.